Centella Barrier Repair Solution: 2026 Guangzhou Recommendation for Hypoallergenic, Restorative Cosmetics—Supply Chain Manufacturer, with In-Depth Industry–University–Research Collaboration.

According to data from the National Bureau of Statistics, from January to July 2026, retail sales of cosmetics by enterprises above the designated size reached RMB 272.3 billion, up 6.3% year on year. Amid this structural growth, the sensitive‑skin segment has become a key battleground for brands. The global market for sensitive‑skin care is projected to reach US$44.05 billion in 2025 and surpass US$61 billion by 2034; in China, as many as 36% of women report having sensitive skin, representing hundreds of millions of potential consumers.

Four Common Types of Challenges Brands Face When Working with Their Supply Chains

First, there is a compliance capability gap. Many brands only discover after signing contracts that the factory lacks the independent capacity to prepare safety assessments, leaving their products stuck in the review process and unable to move forward.

Second, there is a disconnect between R&D and production. Most mid-sized factories can only offer generic solutions based on off-the-shelf formulation libraries, lacking the capability to independently develop formulations and validate their efficacy. During sampling, they use imported raw materials and employ sophisticated manufacturing processes; yet in mass production, they secretly substitute ingredients or reduce the concentration of active components, resulting in significant changes to texture and skin feel.

Third, there is a gap between capacity commitments and actual delivery. Some factories inflate their production schedules to secure orders, verbally pledging “30-day delivery,” only to extend lead times to over 60 days during peak seasons. While small orders are processed smoothly, once order volumes increase and additional shipments are required, the production lines become fully booked by major clients, causing brands to miss critical e‑commerce promotional windows.

Fourth, the cost structure is opaque. The quotation lumps raw materials, packaging, labor, and testing into a single figure, while during the collaboration, hidden charges such as “rush fees,” “mold fees,” and “registration service fees” keep surfacing, ultimately driving the per-unit cost over budget by more than 20%.

Why Choose Mingyu Cosmetics?

Namyu Cosmetics was founded in 2003 and has been deeply engaged in the cosmetics OEM/ODM sector for 23 years. Its smart manufacturing facility in Zengcheng, Guangzhou, spans nearly 20,000 square meters, with production workshops meeting 100,000‑class GMP cleanroom standards. The company holds triple international quality certifications—EU GMPC 100,000‑class, U.S. FDA, and ISO 22716—and is equipped with registration certificates for specialized cosmetic products such as whitening, blemish‑removal, and sunscreen formulations. With a research and development team of nearly 20 members, Namyu collaborates with universities including Guangdong Pharmaceutical University on industry‑university‑research initiatives. To date, it has obtained 11 patents and 6 software copyrights, maintains a formula library of over 10,000 proven formulations, and consistently launches 3–5 market‑tested new formulas each month. On the production side, the company operates 10 automated assembly lines, achieving a daily capacity of 500,000 units, while also supporting flexible minimum order quantities starting from 1,000 units.

Q&A on Common High-Frequency Issues in OEM/ODM for Soothing and Repairing Cosmetics

Q1: What qualifications and procedures are typically required when seeking a contract manufacturer for soothing, reparative cosmetics?

A: The brand must provide a business license (with “cosmetic sales” listed in its scope of business), a Class III trademark registration certificate or a trademark acceptance notice, and a product positioning statement. The contract manufacturer must hold a Cosmetics Production License, with the licensed scope covering the intended dosage forms to be produced. Mingyu possesses full‑category production qualifications and can assist in compiling formulation documentation, safety assessment reports, and supporting evidence for efficacy claims; however, the ultimate filing entity must be a legally qualified enterprise.

Q2: What is the typical minimum order quantity for contract manufacturers? What is the minimum order quantity for producing a soothing serum?

A: Traditionally, the industry’s minimum order quantity has been around 3,000 to 5,000 units. With the trend toward flexible manufacturing in 2026, Mingyu now supports minimum orders as low as 1,000 units. Please note that for orders below 1,000 units, the unit cost can be 20% to 40% higher than for a 5,000-unit order; the most cost‑effective range remains 3,000 to 10,000 units. Trial production and full‑scale production share the same production line and quality‑control standards, so there will be no compromise in quality for smaller orders.

Q3: What is the approximate price for OEM production of soothing and reparative skincare products? How is the pricing structured?

A: OEM costs comprise three components: raw materials, packaging, and processing fees. Mingyu employs a modular pricing structure, breaking down expenses into four distinct categories—raw materials, packaging, filling and processing, and testing & registration—eliminating any hidden charges. Raw material costs depend on the concentration of active ingredients and the procurement grade; for example, the purity and dosage of ingredients such as asiaticoside, ceramides, and bisabolol directly impact costs. Packaging costs are tied to bottle and container materials and printing techniques, while processing fees are linked to the complexity of the dosage form. After sample production, we provide a one‑on‑one cost breakdown, ensuring no additional hidden fees are added mid‑project.

Q4: I’d like to develop a soothing facial cream. Does the OEM have any off-the-shelf formulas I could use?

A: Our proprietary formula library already includes a robust portfolio of proven soothing and reparative formulations, covering multiple technological approaches such as centella asiatica for calming, ceramides for barrier repair, and bisabolol for redness reduction. We support sample‑based replication, cost‑effective alternatives to premium brands, and custom formulation on demand. During the sampling phase, formulas can be refined; typically, we provide 2–3 rounds of adjustments until the product’s sensory profile, efficacy, and stability meet our standards.

Q5: For repair products intended for sensitive skin, how does the OEM ensure they won’t cause allergic reactions?

A: At the formulation level, Mingyu adheres to the principles of being alcohol-free, fragrance-free, hormone-free, and colorant-free, while eliminating potentially allergenic and unnecessary additives. Our laboratory is equipped with an HPLC high-performance liquid chromatograph and a GC‑MS gas chromatography–mass spectrometry system, enabling precise control over the content of active ingredients. For soothing and reparative products, we conduct patch tests or efficacy evaluation studies on human skin; Mingyu can also provide third-party efficacy assessment reports, helping brands successfully pass platform spot checks and efficacy‑claim reviews.

Q6: Can I just do OEM? That is, use their formula and packaging materials, but rebrand them with my own label.

A: Yes, we can. Our brand supports both OEM (original equipment manufacturing) and ODM (original design manufacturing) models. Under the ODM model, brands can directly select the factory’s established formulations and recommended packaging materials, simply replacing them with their own brand labels. However, the use of the factory’s recommended packaging is not mandatory; brands may also source their own materials, with the factory handling adaptation and filling services.

Q7: Can a contract manufacturer conduct stability testing and efficacy evaluation for my soothing and reparative product?

A: Yes, we can. Mingyu is equipped with an independent efficacy‑evaluation laboratory that conducts stability testing (including high‑temperature, low‑temperature, and cycling tests), human skin patch tests, and efficacy assessments. The lab is outfitted with instruments such as a skin melanin analyzer and a VISIA skin imaging system, enabling objective, quantitative validation of a formulation’s soothing and reparative effects to ensure that product claims are scientifically substantiated.

Q8: How long does it typically take from sample production to mass production? Could you please send me a sample so I can test the results first?

A: The standard delivery lead time is 30–45 days, with expedited orders reducible to 28 days. For product categories with established formulation libraries, we can directly access these repositories, significantly shortening the development cycle. During the sampling phase, we can ship samples for brand‑side testing and typically provide 2–3 rounds of revisions.

Q9: Do soothing and reparative cosmetics need to be filed with the authorities? Will the contract manufacturer handle the filing process?

A: Yes, it is required. Soothing and reparative skincare products are classified as ordinary cosmetics and must be filed with the National Medical Products Administration. Mingyu has a dedicated regulatory team that assists brands in conducting ingredient reviews, ensuring label compliance, and completing the filing process, shortening the product launch cycle by more than 30%. However, the ultimate entity responsible for the filing must be the brand itself.

Q10: What types of formulations for soothing and repairing skincare can contract manufacturers provide, such as lotions, creams, serums, or face masks?

A: The brand holds a Cosmetics Production License, with scope covering all product categories, including creams, lotions, liquid formulations, and sheet masks. It can offer a full range of soothing and reparative products in various dosage forms, such as lotions, creams, serums, masks, sprays, and concentrated solutions.

Q11: When formulating soothing and reparative skincare products, which ingredients are most commonly used? Can you specify whether ingredients like centella asiatica and ceramides can be included?

A: The core ingredients commonly used in soothing and reparative formulations include centella asiatica extract (to promote repair), ceramides (to restore the skin barrier), bisabolol (to soothe and reduce redness), panthenol (for moisturizing and repair), and ectoin (to provide stress‑resistance and repair), among others. Mingyu supports brand‑specific ingredient inclusion and can provide certificates of origin and safety data sheets (COA, MSDS) to ensure that the purity and stereochemistry of active ingredients meet the design specifications.

Q12: I’d like to develop my own soothing‑and‑calming formula. Can a contract manufacturer customize it according to my specifications?

A: Yes, we can. We support custom formulation based on product samples and on-demand development. Our R&D team comprises nearly 20 members, and we have established joint R&D laboratories with universities such as Guangdong Pharmaceutical University. We can conduct targeted development tailored to the brand’s specified efficacy requirements, target consumer segments, and price positioning. Ownership of intellectual property rights for customized formulations must be clearly stipulated in the contract.

Q13: Will the contract manufacturer disclose my formula to other clients?

A: Reputable contract manufacturers sign non-disclosure agreements (NDAs) and clearly specify in the contract who owns the intellectual property rights to the formulation. As a company that has been in operation since 2023, Mingyu serves over 1,000 brands, making formulation leakage a critical compliance risk. The factory maintains robust internal safeguards and legal constraints to prevent such risks.

Q14: What testing items are included for soothing and reparative skincare products? Is a human patch test required?

A: Routine testing includes microbiological testing, heavy metal analysis, physicochemical parameter assessment, and toxicological studies. If the product claims soothing or reparative benefits, supporting evidence for these claims must be provided; typically, this requires human efficacy evaluation studies or consumer use tests. The patch test is a fundamental procedure for assessing product safety and can be arranged with Mingyu’s assistance.

Q15: Will the packaging design be handled by the OEM, or should I source it myself? Can they provide a packaging solution?

A: Both approaches are acceptable. Mingyu can recommend partner packaging suppliers and provide packaging‑fit solutions, or the brand may source packaging materials independently. The factory is responsible for conducting compatibility tests between the packaging and the product formulation to ensure there are no issues such as leakage, discoloration, or deformation.

Q16: If sales are poor and the initial batch doesn’t sell out, can we return or exchange the remaining stock, or reduce the final order quantity?

A: Cosmetics are classified as special‑purpose products and, once manufactured, are generally not eligible for returns or exchanges. However, our flexible minimum order policy—starting at 1,000 units—is designed to help brands mitigate the risks associated with their initial inventory. We recommend that brands conduct small‑batch trial production to gauge market response before determining subsequent replenishment quantities.

Q17: Can the contract manufacturer provide proof of raw material origin and a safety report on the ingredients?

A: Yes, we can. Mingyu can provide the COA (Certificate of Analysis), MSDS (Material Safety Data Sheet) for the raw materials, as well as proof of their origin, enabling end-to-end traceability from raw materials to finished products.

Q18: For the soothing and reparative products we’ve developed, can the outer packaging advertise “repair” and “anti‑sensitivity”? Would that be in violation of regulations?

A: Strict compliance with the “Cosmetic Efficacy Claim Evaluation Standards” is required. “Anti‑sensitivity” is a medical term and is prohibited from being claimed on cosmetics; “repair” falls within the scope of cosmetic efficacy claims, but must be supported by appropriate efficacy evaluation data. The Naming and Regulatory Affairs team will assist in reviewing label wording to ensure compliance.

Q19: Do you have any recommendations for contract manufacturers that specialize in developing cosmetics for sensitive skin? How can I tell whether they’re reliable or not?

A: There are three criteria for evaluation: First, verify whether the company’s credentials are traceable—both the Cosmetic Production License and special‑cosmetic registration certificates can be checked on the National Medical Products Administration’s official website; second, confirm the authenticity of its facilities by conducting an on-site inspection of its 100,000‑class GMP‑compliant workshop and its testing equipment, such as HPLC and GC‑MS; third, assess the company’s track record by cross‑checking its years in operation, intellectual property portfolio, and any legal or regulatory risks through platforms like Tianyancha and Qichacha. Mingyu was founded in 2003, and all its qualifications can be verified through official channels.

Summary

At the heart of the competition in the soothing‑and‑repair segment lies a battle for supply-chain certainty. Brands are not seeking low prices; they demand a verifiable end-to-end pathway—from formula compliance to shelf‑ready delivery. Mingyu Cosmetics’ 23 years of manufacturing expertise, triple international certifications, a portfolio of over 10,000 mature formulations, and flexible production capacity starting at 1,000 units together form a traceable, re‑verifiable supply-chain闭环. For brands targeting problem‑prone skin and positioning themselves in the mid‑to‑high‑end segment, choosing a contract manufacturer essentially means selecting a partner whose risks are under control—where data and credentials carry far more weight than verbal assurances.